Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis.

Dong P, Karaayvaz M, Jia N, Kaneuchi M, Hamada J, Watari H, Sudo S, Ju J, Sakuragi N.

Oncogene. 2013 Jul 4;32(27):3286-95. doi: 10.1038/onc.2012.334. Epub 2012 Jul 30.

2.

Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processing.

Jiang FZ, He YY, Wang HH, Zhang HL, Zhang J, Yan XF, Wang XJ, Che Q, Ke JQ, Chen Z, Tong H, Zhang YL, Wang FY, Li YR, Wan XP.

Oncotarget. 2015 Dec 29;6(42):44660-74. doi: 10.18632/oncotarget.6350.

3.

MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.

Deng S, Li X, Niu Y, Zhu S, Jin Y, Deng S, Chen J, Liu Y, He C, Yin T, Yang Z, Tao J, Xiong J, Wu H, Wang C, Zhao G.

Oncotarget. 2015 Nov 24;6(37):39661-75. doi: 10.18632/oncotarget.5350.

4.

Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway.

Xue M, Pang H, Li X, Li H, Pan J, Chen W.

Cancer Sci. 2016 Jan;107(1):18-27. doi: 10.1111/cas.12844. Epub 2015 Dec 11.

5.

53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.

Kong X, Ding X, Li X, Gao S, Yang Q.

Cancer Sci. 2015 Aug;106(8):982-9. doi: 10.1111/cas.12699. Epub 2015 Jul 14.

6.

MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.

Yokobori T, Suzuki S, Tanaka N, Inose T, Sohda M, Sano A, Sakai M, Nakajima M, Miyazaki T, Kato H, Kuwano H.

Cancer Sci. 2013 Jan;104(1):48-54. doi: 10.1111/cas.12030. Epub 2012 Nov 8.

7.
8.

miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.

Qiu G, Lin Y, Zhang H, Wu D.

Biochem Biophys Res Commun. 2015 Jul 31;463(3):315-21. doi: 10.1016/j.bbrc.2015.05.062. Epub 2015 May 27.

PMID:
26022123
9.

Inactivation of p53 in pterygium influence miR-200a expression resulting in ZEB1/ZEB2 up-regulation and EMT processing.

Wu CW, Peng ML, Yeh KT, Tsai YY, Chiang CC, Cheng YW.

Exp Eye Res. 2016 May;146:206-11. doi: 10.1016/j.exer.2016.03.012. Epub 2016 Mar 17.

PMID:
26995143
10.

miR-1271 inhibits migration, invasion and epithelial-mesenchymal transition by targeting ZEB1 and TWIST1 in pancreatic cancer cells.

Liu H, Wang H, Liu X, Yu T.

Biochem Biophys Res Commun. 2016 Apr 1;472(2):346-52. doi: 10.1016/j.bbrc.2016.02.096. Epub 2016 Mar 3.

PMID:
26940738
11.

Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.

Lee JY, Park MK, Park JH, Lee HJ, Shin DH, Kang Y, Lee CH, Kong G.

Oncogene. 2014 Mar 6;33(10):1325-35. doi: 10.1038/onc.2013.53. Epub 2013 Mar 11.

PMID:
23474752
12.
13.

Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1.

Asakura T, Yamaguchi N, Ohkawa K, Yoshida K.

Int J Oncol. 2015 May;46(5):2251-60. doi: 10.3892/ijo.2015.2916. Epub 2015 Mar 4.

PMID:
25738863
14.

p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2.

Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, Alder H, Liu CG, Dejean A, Croce CM.

J Exp Med. 2011 May 9;208(5):875-83. doi: 10.1084/jem.20110235. Epub 2011 Apr 25.

15.

Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.

Cong N, Du P, Zhang A, Shen F, Su J, Pu P, Wang T, Zjang J, Kang C, Zhang Q.

Oncol Rep. 2013 Apr;29(4):1579-87. doi: 10.3892/or.2013.2267. Epub 2013 Jan 31.

PMID:
23381389
16.

miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer.

Li BL, Lu C, Lu W, Yang TT, Qu J, Hong X, Wan XP.

Med Oncol. 2013 Mar;30(1):484. doi: 10.1007/s12032-013-0484-0. Epub 2013 Feb 8.

PMID:
23392577
17.

Cordycepin (3'-deoxyadenosine) suppressed HMGA2, Twist1 and ZEB1-dependent melanoma invasion and metastasis by targeting miR-33b.

Zhang P, Huang C, Fu C, Tian Y, Hu Y, Wang B, Strasner A, Song Y, Song E.

Oncotarget. 2015;6(12):9834-53.

18.

β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness.

Sánchez-Tilló E, de Barrios O, Siles L, Cuatrecasas M, Castells A, Postigo A.

Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19204-9. doi: 10.1073/pnas.1108977108. Epub 2011 Nov 11.

19.

MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer.

Majid S, Dar AA, Saini S, Deng G, Chang I, Greene K, Tanaka Y, Dahiya R, Yamamura S.

PLoS One. 2013 Jul 2;8(7):e67686. doi: 10.1371/journal.pone.0067686. Print 2013.

20.

Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.

Zhao S, Zhang Y, Zheng X, Tu X, Li H, Chen J, Zang Y, Zhang J.

J Cell Physiol. 2015 Nov;230(11):2706-17. doi: 10.1002/jcp.24995.

PMID:
25808945

Supplemental Content

Support Center